Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Oct 14, 2021

Total Value: $287M (100.0% shares, 0.0% debt)

Holdings (29)

ACRS ACLARIS THERAPEUTICS INC 10.2%

Value $29.31M Shares 1,668,987 Est. Cost $11.32 Unrealized +100.6%

— SATSUMA PHARMACEUTICALS INC 7.6%

Value $21.83M Shares 3,096,729 Est. Cost $6.15 Unrealized —

CELC CELCUITY INC 7.3%

Value $20.9M Shares 870,967 Est. Cost $25.73 Unrealized 0.0%

CCCC C4 THERAPEUTICS INC 6.3%

Value $18.2M Shares 481,094 Est. Cost $29.00 Unrealized +23.5%

— CYMABAY THERAPEUTICS INC 5.4%

Value $15.39M Shares 3,529,465 Est. Cost $5.02 Unrealized —

— CONSTELLATION PHARMCETICLS I 5.2%

Value $14.9M Shares 440,869 Est. Cost $29.62 Unrealized —

CYTK CYTOKINETICS INC 4.9%

Value $13.94M Shares 704,317 Est. Cost $23.48 Unrealized 0.0%

KURA KURA ONCOLOGY INC 4.5%

Value $12.96M Shares 621,493 Est. Cost $31.30 Unrealized -20.7%

COGT COGENT BIOSCIENCES INC 3.9%

Value $11.09M Shares 1,367,582 Est. Cost $10.30 Unrealized -18.0%

— IVERIC BIO INC 3.8%

Value $11.03M Shares 1,748,241 Est. Cost $6.71 Unrealized —

CLDX CELLDEX THERAPEUTICS INC NEW 3.8%

Value $10.82M Shares 323,437 Est. Cost $18.18 Unrealized +51.0%

MGNX MACROGENICS INC 3.7%

Value $10.58M Shares 393,850 Est. Cost $28.69 Unrealized +2.1%

— VISTAGEN THERAPEUTICS INC 3.7%

Value $10.49M Shares 3,331,315 Est. Cost $1.97 Unrealized —

PTGX PROTAGONIST THERAPEUTICS INC 3.3%

Value $9.452M Shares 210,600 Est. Cost $21.52 Unrealized +53.4%

— ESSA PHARMA INC 2.8%

Value $8.054M Shares 281,911 Est. Cost $28.87 Unrealized —

— KRONOS BIO INC 2.5%

Value $7.157M Shares 298,839 Est. Cost $29.87 Unrealized —

GNCAQ GENOCEA BIOSCIENCES INC 2.4%

Value $6.855M Shares 2,929,447 Est. Cost $2.54 Unrealized -5.0%

MREO MEREO BIOPHARMA GROUP PLC 2.3%

Value $6.529M Shares 2,059,729 Est. Cost $3.56 Unrealized —

DYN DYNE THERAPEUTICS INC 2.2%

Value $6.42M Shares 305,125 Est. Cost $19.35 Unrealized -2.8%

XENE XENON PHARMACEUTICALS INC 2.1%

Value $6.076M Shares 326,336 Est. Cost $12.22 Unrealized +50.9%

— MERSANA THERAPEUTICS INC 2.0%

Value $5.829M Shares 429,228 Est. Cost $20.04 Unrealized —

KALV KALVISTA PHARMACEUTICALS INC 1.9%

Value $5.431M Shares 226,671 Est. Cost $26.27 Unrealized -0.4%

PMVP PMV PHARMACEUTICALS INC 1.5%

Value $4.27M Shares 125,000 Est. Cost $39.23 Unrealized -14.9%

IVA INVENTIVA SA 1.2%

Value $3.581M Shares 262,658 Est. Cost $14.53 Unrealized —

— SERES THERAPEUTICS INC 1.2%

Value $3.469M Shares 145,453 Est. Cost $20.68 Unrealized —

— CATABASIS PHARMACEUTICALS IN 1.2%

Value $3.412M Shares 1,617,000 Est. Cost $2.11 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 1.2%

Value $3.409M Shares 186,405 Est. Cost $18.72 Unrealized -8.6%

SPRY SILVERBACK THERAPEUTICS INC 1.0%

Value $3.001M Shares 97,143 Est. Cost $33.40 Unrealized -4.0%

— BCLS ACQUISITION CORP 0.9%

Value $2.633M Shares 250,000 Est. Cost $11.14 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACRS	ACLARIS THERAPEUTICS INC	1,668,987	$29.31M	10.2%	$11.32	+100.6%	COM	00461U105
—	SATSUMA PHARMACEUTICALS INC	3,096,729	$21.83M	7.6%	$6.15	—	COM	80405P107
CELC	CELCUITY INC	870,967	$20.9M	7.3%	$25.73	0.0%	COM	15102K100
CCCC	C4 THERAPEUTICS INC	481,094	$18.2M	6.3%	$29.00	+23.5%	COM STK	12529R107
—	CYMABAY THERAPEUTICS INC	3,529,465	$15.39M	5.4%	$5.02	—	COM	23257D103
—	CONSTELLATION PHARMCETICLS I	440,869	$14.9M	5.2%	$29.62	—	COM	210373106
CYTK	CYTOKINETICS INC	704,317	$13.94M	4.9%	$23.48	0.0%	COM NEW	23282W605
KURA	KURA ONCOLOGY INC	621,493	$12.96M	4.5%	$31.30	-20.7%	COM	50127T109
COGT	COGENT BIOSCIENCES INC	1,367,582	$11.09M	3.9%	$10.30	-18.0%	COM	19240Q201
—	IVERIC BIO INC	1,748,241	$11.03M	3.8%	$6.71	—	COM	46583P102
CLDX	CELLDEX THERAPEUTICS INC NEW	323,437	$10.82M	3.8%	$18.18	+51.0%	COM NEW	15117B202
MGNX	MACROGENICS INC	393,850	$10.58M	3.7%	$28.69	+2.1%	COM	556099109
—	VISTAGEN THERAPEUTICS INC	3,331,315	$10.49M	3.7%	$1.97	—	COM NEW	92840H202
PTGX	PROTAGONIST THERAPEUTICS INC	210,600	$9.452M	3.3%	$21.52	+53.4%	COM	74366E102
—	ESSA PHARMA INC	281,911	$8.054M	2.8%	$28.87	—	COM NEW	29668H708
—	KRONOS BIO INC	298,839	$7.157M	2.5%	$29.87	—	COM	50107A104
GNCAQ	GENOCEA BIOSCIENCES INC	2,929,447	$6.855M	2.4%	$2.54	-5.0%	COM NEW	372427401
MREO	MEREO BIOPHARMA GROUP PLC	2,059,729	$6.529M	2.3%	$3.56	—	ADS	589492107
DYN	DYNE THERAPEUTICS INC	305,125	$6.42M	2.2%	$19.35	-2.8%	COM	26818M108
XENE	XENON PHARMACEUTICALS INC	326,336	$6.076M	2.1%	$12.22	+50.9%	COM	98420N105
—	MERSANA THERAPEUTICS INC	429,228	$5.829M	2.0%	$20.04	—	COM	59045L106
KALV	KALVISTA PHARMACEUTICALS INC	226,671	$5.431M	1.9%	$26.27	-0.4%	COM	483497103
PMVP	PMV PHARMACEUTICALS INC	125,000	$4.27M	1.5%	$39.23	-14.9%	COM	69353Y103
IVA	INVENTIVA SA	262,658	$3.581M	1.2%	$14.53	—	ADS	46124U107
—	SERES THERAPEUTICS INC	145,453	$3.469M	1.2%	$20.68	—	COM	81750R102
—	CATABASIS PHARMACEUTICALS IN	1,617,000	$3.412M	1.2%	$2.11	—	COM NEW	14875P206
VRDN	VIRIDIAN THERAPEUTICS INC	186,405	$3.409M	1.2%	$18.72	-8.6%	COM	92790C104
SPRY	SILVERBACK THERAPEUTICS INC	97,143	$3.001M	1.0%	$33.40	-4.0%	COM	82835W108
—	BCLS ACQUISITION CORP	250,000	$2.633M	0.9%	$11.14	—	COM CL A	G0904B105